EP2714937
BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
31.5.2012EP published:
14.11.2018EP application number:
12793322.4
EPO information:
European Patent Register
Max expiry date:
30.5.2032
Title:
BIOMARKERS FOR PREDICTING AND ASSESSING RESPONSIVENESS OF THYROID AND KIDNEY CANCER SUBJECTS TO LENVATINIB COMPOUNDS
Timeline
Today
31.5.2012EP application
14.11.2018EP Publication
Owner
Name:
Eisai R&D Management Co., Ltd.Address:
6-10, Koishikawa 4-chome Bunkyo-ku, 112-8088, Tokyo, JP
Inventor
Name:
FUNAHASHI, YasuhiroAddress:
Tsukuba-shi,Ibaraki, JP
Name:
KADOWAKI, TadashiAddress:
Tsukuba-shi,Ibaraki, JP
Name:
MATSUI, JunjiAddress:
Tsukuba-shi,Ibaraki, JP
Name:
SIMON, Jason S.Address:
Woodcliff LakeNew Jersey, US
Name:
XU, LucyAddress:
Woodcliff LakeNew Jersey, US
Priority
Number:
201161493294 PDate:
3.6.2011Country:
US
Classification
Categories:
C12Q 1/6886